Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stevanato Group S.P.A. (NY: STVN )

28.50 +0.96 (+3.49%)
Official Closing Price Updated: 7:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 104,403
Open 27.78
Bid (Size) 23.50 (1)
Ask (Size) 45.47 (1)
Prev. Close 27.54
Today's Range 27.78 - 28.55
52wk Range 13.71 - 29.67
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stevanato Group to Present at Upcoming Investor Conferences
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Reports First Quarter 2023 Financial Results
From Stevanato Group S.p.A.
Via Business Wire

Performance

YTD
+62.95%
+62.95%
1 Month
+6.15%
+6.15%
3 Month
+16.90%
+16.90%
6 Month
+82.23%
+82.23%
1 Year
+74.85%
+74.85%

More News

Read More
Earnings Preview For Stevanato Gr
Via Benzinga
Stevanato Group to Present at BofA Securities Healthcare Conference
From Stevanato Group S.p.A.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
The Latest Analyst Ratings for Stevanato Group
Via Benzinga
A Preview Of Stevanato Group's Earnings
Via Benzinga
Recap: Stevanato Group Q2 Earnings
Via Benzinga
Stevanato Group to Report First Quarter 2023 Financial Results on May 4, 2023
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Collaborates with Thermo Fisher Scientific to Bring its Innovative On-Body Delivery System Platform to Market
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Collaborates with Recipharm to Develop and Manufacture Pre-fillable Syringes for Use in a New Soft Mist Inhaler for the Inhalation of Sensitive Biological Products
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Secures €130 Million ESG-Linked Financing From BNL BNP Paribas and Cassa Depositi e Prestiti to Support Sustainable Global Growth
From Stevanato Group
Via Business Wire
Stevanato Group Reports Fourth Quarter and Fiscal Year 2022 Financial Results
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 2, 2023
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Collaborates with Transcoject to Provide Pre-Fillable Syringe Polymer Options for Pharma
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Present at Upcoming Investor Conference
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Reports Third Quarter 2022 Financial Results
From Stevanato Group S.p.A.
Via Business Wire
Earnings Scheduled For November 8, 2022
Via Benzinga
Stevanato Group and Gerresheimer AG Present EZ-fill Smart™, a New and Innovative Ready-To-Use Vial Platform
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group and DWK Life Sciences Sign Non-Exclusive Distribution Agreement for EZ-fill® Platform Products
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Report Third Quarter 2022 Financial Results on November 8, 2022
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group to Present at Upcoming Investor Conference
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group and Gerresheimer AG Announce Collaboration on the Development of an Innovative Ready-To-Use Vial Platform for the Pharmaceutical Industry
From Stevanato Group S.p.A.
Via Business Wire
Stevanato Group Reports Second Quarter 2022 Financial Results
From Stevanato Group S.p.A.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.